Literature DB >> 8191404

Flow through clots determines the rate and pattern of fibrinolysis.

A Blinc1, S D Kennedy, R G Bryant, V J Marder, C W Francis.   

Abstract

Thrombolytic therapy depends on penetration of plasminogen activator into clots which occurs through diffusion and flow. An in vitro system has been developed to characterize the rate and pattern of fibrinolysis in relation to flow through occlusive clots exposed to a pressure gradient. Whole blood clots formed in plastic tubes were perfused with plasma containing 1 microgram/ml tissue plasminogen activator (t-PA) and 0.5 or 1 mmol/l gadolinium-diethylentriamine pentaacetic acid (Gd-DTPA), a paramagnetic substance used as a contrast enhancer for magnetic resonance (MR) imaging. T1-weighted spin echo MR images were obtained during clot perfusion at 3-5 min intervals for 45 min. Characteristic signal intensities allowed identification of non-perfused, perfused but non-lysed, and completely lysed areas of clot. A spatially resolved time course of perfusion and subsequent lysis was constructed for 10 clots. Plasma flowed non-uniformly through clots forming asymmetric channels that left some areas non-perfused. The longitudinal velocity of flow through the dominant channel was 1.6 +/- 0.7 mm/min. The flow rate during the first five minutes was 7.5 +/- 6.5 microliters/min and 15.3 +/- 10 microliters/min between min 26-30 in clots that had not completely recanalized by that time. A sharp increase in flow was noted at the time of recanalization that occurred at 37 +/- 11 min. Clot lysis followed the pattern of perfusion through the dominant channel after a lag time of 13 +/- 4 min, representing the time required for enzymatic processes. The delay time between perfusion and lysis was longer in regions with slower flow indicating that the rate of t-PA delivery influenced the rate of fibrinolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191404

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

1.  Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.

Authors:  S Atar; H Luo; Y Birnbaum; T Nagai; R J Siegel
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

2.  Early fatal hemorrhage after endovascular cerebral aneurysm treatment with a flow diverter (SILK-Stent): do we need to rethink our concepts?

Authors:  Bernd Turowski; Stephan Macht; Zolt Kulcsár; Daniel Hänggi; Walter Stummer
Journal:  Neuroradiology       Date:  2010-03-26       Impact factor: 2.804

3.  A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke.

Authors:  Andrei V Alexandrov; Robert Mikulik; Marc Ribo; Vijay K Sharma; Annabelle Y Lao; Georgios Tsivgoulis; Rebecca M Sugg; Andrew Barreto; Paul Sierzenski; Marc D Malkoff; James C Grotta
Journal:  Stroke       Date:  2008-03-20       Impact factor: 7.914

4.  Histotripsy Thrombolysis on Retracted Clots.

Authors:  Xi Zhang; Gabe E Owens; Charles A Cain; Hitinder S Gurm; Jonathan Macoskey; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2016-05-07       Impact factor: 2.998

5.  Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent.

Authors:  Kathryn C Gersh; Sergei Zaitsev; Douglas B Cines; Vladimir Muzykantov; John W Weisel
Journal:  Blood       Date:  2011-03-09       Impact factor: 22.113

6.  Mathematical modeling of blood clot fragmentation during flow-mediated thrombolysis.

Authors:  Franci Bajd; Igor Serša
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

7.  Finger-like lysing patterns of blood clots.

Authors:  A Zidansek; A Blinc; G Lahajnar; D Keber; R Blinc
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

8.  Integrated Histotripsy and Bubble Coalescence Transducer for Thrombolysis.

Authors:  Aiwei Shi; Jonathan Lundt; Zilin Deng; Jonathan Macoskey; Hitinder Gurm; Gabe Owens; Xi Zhang; Timothy L Hall; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2018-09-30       Impact factor: 2.998

9.  Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.

Authors:  Jonathan T Sutton; Nikolas M Ivancevich; Stephen R Perrin; Deborah C Vela; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2013-03-01       Impact factor: 2.998

Review 10.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.